Table 2 ROC analysis of ATM, graves’ disease, and healthy controls.
Parameters | Group comparison | AUC (95% CI) | Sensitivity (%) | Specificity (%) | Cut-off value | P value |
|---|---|---|---|---|---|---|
CD40 (pg/ml) | ATM vs. GD | 0.99(0.97-1.00) | 94.1 | 94.1 | 209.92 | < 0.01 |
ATM vs. Control | 1.00(1.00–1.00) | 100 | 100 | 195.04 | < 0.01 | |
FT3 (pmol/L) | ATM vs. GD | 0.92(0.83-1.00) | 94.1 | 82.4 | 14.82 | < 0.01 |
ATM vs. Control | 1.00(1.00–1.00) | 100 | 100 | 7.42 | < 0.01 | |
FT4 (pmol/L) | ATM vs. GD | 0.89(0.78-1.00) | 88.2 | 88.2 | 40.94 | < 0.01 |
ATM vs. Control | 0.99(0.96-1.00) | 94.1 | 100 | 19.74 | < 0.01 | |
TSH (mIU/L) | ATM vs. GD | 0.45(0.25–0.65) | 17.6 | 76.5 | 0.02 | 0.52 |
ATM vs. Control | 0.00(0.00–0.00) | 0.37 | 0 | 0 | < 0.01 | |
TGAb (%) | ATM vs. GD | 0.56(0.36–0.76) | 18.94 | 64.7 | 58.8 | 0.76 |
ATM vs. Control | 0.72(0.51–0.92) | 19.27 | 64.7 | 100 | 0.03 | |
TRAb (IU/L) | ATM vs. GD | 0.65(0.46–0.84) | 19.55 | 47.1 | 82.4 | 0.14 |
ATM vs. Control | 1.00(1.00–1.00) | 1.42 | 100 | 100 | < 0.01 |
